2BB score and signals
BridgeBio Oncology Therapeutics, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 22 | Weak |
| Quality | 80 | Very Strong |
| Risk | 0 | Very Low |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 2016 |
| Employees | 106 |
| 52-week range | $7.00 – $14.87 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -0.5918 | — | $0.00 |
| 2026-07-29 | — | -0.5766 | — | $0.00 |
| 2026-05-11 | — | -0.5406 | — | $0.00 |
| 2026-03-03 | — | -0.598 | — | $0.00 |
2BBBullish & Bearish